https://www.selleckchem.com/pr....oducts/rimiducid-ap1
Our understanding of diffuse midline glioma (DMG) biology inclusive of diffuse intrinsic pontine glioma has been revolutionized by the discovery of novel mutations on the tails of histone 3, leading to the reclassification in 2016 of 'diffuse midline glioma, H3 K27M-mutant.' Given the abundance of basic, translational, and clinical information put forth in recent years, a review of the epigenetics of diffuse midline glioma is warranted. Literature for the epigenetics of diffuse midline glioma published from 1989 to 2019 was rev
Like
Comment
Share
